scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0920-9964(00)00185-7 |
P698 | PubMed publication ID | 11705717 |
P2093 | author name string | J A Suhr | |
M B Spitznagel | |||
P2860 | cites work | Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model | Q68053354 |
Syndromes of chronic schizophrenia | Q68390890 | ||
Comparing borderline definitions: DSM-III borderline and schizotypal personality disorders | Q69589245 | ||
Heterogeneity in schizophrenia: a cluster-analytic approach | Q70900042 | ||
The factor structure of "schizotypal' traits: a large replication study | Q71167412 | ||
A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia | Q72640709 | ||
Neuropsychological performance and positive and negative symptoms in schizophrenia | Q93661075 | ||
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria | Q28315201 | ||
The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy | Q34187608 | ||
Relations between attentional deficits and clinical symptoms in schizophrenic outpatients | Q34354444 | ||
Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy | Q35266368 | ||
Cognitive inhibition and schizophrenic symptom subgroups | Q38461681 | ||
Further evidence for a multidimensional personality disposition to schizophrenia in terms of cognitive inhibition | Q38463536 | ||
Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders | Q38485973 | ||
The positive/negative symptom distinction in schizophrenia. Validity and etiological relevance | Q39612794 | ||
The multidimensionality of schizotypy | Q40539042 | ||
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews. | Q40914439 | ||
The factor structure of schizotypal symptoms in a clinical population | Q40957150 | ||
Pre-frontal structural and functional deficits associated with individual differences in schizotypal personality | Q41095250 | ||
Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study | Q41186497 | ||
Positive and negative schizophrenic symptoms, attention, and information processing | Q41503281 | ||
Span of apprehension performance, neuropsychological functioning, and indices of psychosis-proneness. | Q41588237 | ||
Positive and negative symptoms in schizophrenia. A cluster-analytic approach. | Q43410939 | ||
The distinction of positive and negative symptoms. The failure of a two-dimensional model | Q43996898 | ||
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 | ||
The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results | Q44275686 | ||
Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function | Q45832281 | ||
Sensory input deficits and negative symptoms in schizophrenic patients | Q46105828 | ||
Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology | Q47181537 | ||
Magical ideation as an indicator of schizotypy | Q47577801 | ||
Schizotypy in community samples: the three-factor structure and correlation with sustained attention | Q47777095 | ||
Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis | Q48411306 | ||
Schizotypal Personality Questionnaire and Wisconsin Card Sorting Test in a population of DSM-III-R schizophrenic patients and control subjects | Q48459119 | ||
Negative and positive dimensions of schizotypal personality disorder | Q48580055 | ||
Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder | Q48591850 | ||
Schizophrenic syndromes and frontal lobe performance | Q48774771 | ||
Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients | Q48941072 | ||
Symptomatic and neuropsychological components of defect states | Q48984386 | ||
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia | Q49114755 | ||
Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. | Q50866944 | ||
Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia. | Q50940023 | ||
Patterns of cognitive asymmetry and syndromes of schizotypal personality. | Q52019074 | ||
Attentional vulnerability indicators, thought disorder, and negative symptoms. | Q52263264 | ||
Validity of the Trail Making Test as an Indicator of Organic Brain Damage | Q64357777 | ||
Body-image aberration in Schizophrenia | Q67368803 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuropsychology | Q3872 |
P304 | page(s) | 241-250 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | Factor versus cluster models of schizotypal traits. II: relation to neuropsychological impairment. | |
P478 | volume | 52 |
Q50476151 | Are deficits in cognition associated with psychotic-like experiences after cannabis? |
Q21203802 | Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level |
Q52350481 | Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis. |
Q38011879 | Cognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia research |
Q51043051 | Contribution of specific cognitive dysfunction to people with schizotypal personality |
Q36765010 | Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learning |
Q57978272 | Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy |
Q37333739 | Embrained drives to perform extraordinary roles predict schizotypal traits in the general population |
Q35680056 | Examining the Psychosis Continuum |
Q52005237 | Executive function assessed by memory updating and random generation in schizotypal individuals. |
Q74268361 | Executive function deficits associated with symptoms of schizotypy and obsessive-compulsive disorder |
Q37075916 | Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia |
Q30442031 | Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia |
Q63391397 | Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population |
Q38259558 | The Duality of Schizotypy: Is it Both Dimensional and Categorical? |
Search more.